Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Cancer Survival Analysis01:21

Cancer Survival Analysis

448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

570
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
570
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Menopause01:28

Menopause

248
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
248
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Colorectal cancer screening: An update to the American Cancer Society guideline, 2026.

CA: a cancer journal for clinicians·2026
Same author

Long-term trends in cancer mortality by rural-urban status, United States, 1969-2023.

Journal of the National Cancer Institute·2026
Same author

Colorectal cancer statistics, 2026.

CA: a cancer journal for clinicians·2026
Same author

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Cancer statistics, 2026.

CA: a cancer journal for clinicians·2026
Same author

American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.

CA: a cancer journal for clinicians·2025
Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026
Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026
Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Sep 9, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Estadísticas sobre el cáncer de próstata en 2025

Tyler B Kratzer1, Natalia Mazzitelli1, Jessica Star1

  • 1Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.

CA: a cancer journal for clinicians
|September 2, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La incidencia del cáncer de próstata está aumentando, particularmente en etapas avanzadas en hombres más jóvenes. Existen importantes disparidades raciales en el diagnóstico y la mortalidad, lo que pone de relieve la necesidad de mejorar la detección temprana y la atención equitativa.

Palabras clave:
pruebas de detección de cáncerEstadísticas sobre el cáncervigilancia del cáncerCáncer de próstataetapa en el diagnóstico

Más Videos Relacionados

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.0K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.0K

Área de la Ciencia:

  • En el campo de la oncología
  • Epidemiología
  • Salud pública

Sus antecedentes:

  • El cáncer de próstata es el cáncer más común en los hombres estadounidenses.
  • La incidencia de cáncer de próstata avanzado está aumentando rápidamente.
  • Las disparidades raciales significativas en los resultados del cáncer de próstata persisten.

Objetivo del estudio:

  • Para analizar las tendencias de incidencia y mortalidad del cáncer de próstata.
  • Examinar las tendencias por etapa, edad y raza/etnia.
  • Identificar las disparidades e informar las estrategias de salud pública.

Principales métodos:

  • Se utilizaron datos de incidencia y mortalidad de la población.
  • Las fuentes de datos incluyen el Instituto Nacional del Cáncer y los CDC.
  • El análisis abarcó las tendencias de 2007 a 2021, estratificadas por factores demográficos y etapa de la enfermedad.

Principales resultados:

  • La incidencia del cáncer de próstata se invirtió de disminuir a un aumento anual del 3,0% (2014-2021).
  • Las tendencias crecientes son notables para la enfermedad en estadio distante en hombres más jóvenes y regional/distante en hombres mayores.
  • Las disparidades raciales incluyen tasas de diagnóstico localizadas más bajas para los indios americanos / nativos de Alaska, los asiáticos americanos / isleños del Pacífico y los hombres hispanos, y una mayor mortalidad para los indios americanos / nativos de Alaska y los hombres negros.

Conclusiones:

  • El aumento de los diagnósticos de cáncer de próstata avanzado y las disparidades raciales persistentes requieren mayores esfuerzos de detección temprana.
  • Las estrategias deben abordar el sobrediagnóstico y las barreras a los resultados equitativos del cáncer de próstata.
  • Se necesitan intervenciones urgentes de salud pública para mitigar estas tendencias.